Ongoing Interventional Clinical Trial Study Drugs
SAM.GOV Due: June 13, 2025 at 04:00 PM UTC
In-Active Combined Synopsis/Solicitation SBA Source Url

Summary

The opportunity titled 'Ongoing Interventional Clinical Trial Study Drugs' is a combined synopsis/solicitation issued by the National Institutes of Health (NIH). This project involves conducting interventional clinical trials related to study drugs, which requires specialized knowledge in clinical research and drug development. Contractors or businesses with expertise in clinical trial management, pharmaceutical research, and compliance with federal regulations are encouraged to bid on this opportunity. The work will take place in Bethesda, Maryland, and is set aside for small businesses, emphasizing the need for qualified small contractors to participate in this important health research initiative.
Description

Please see attached document

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
339112
Set Aside
SBA : Total Small Business Set-Aside (FAR 19.5)
Place of Performance
Bethesda , Maryland 20892
Point of Contact
Full Name Email Phone Type
Lynda Cole [email protected] 3014027220 primary
Attachments
  • Atorvastatin+and+Plecebo.docx